---
title: Comparison of an Electronic Version of Selected COPD PRO Instruments With the Original Versions
nct_id: NCT01875302
overall_status: COMPLETED
sponsor: nSpire Health, Inc.
study_type: OBSERVATIONAL
primary_condition: COPD
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01875302.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01875302"
ct_last_update_post_date: 2013-06-19
last_seen_at: "2026-05-12T06:25:04.485Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Comparison of an Electronic Version of Selected COPD PRO Instruments With the Original Versions

**NCT ID:** [NCT01875302](https://clinicaltrials.gov/study/NCT01875302)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 20
- **Lead Sponsor:** nSpire Health, Inc.
- **Conditions:** COPD
- **Start Date:** 2013-02
- **Completion Date:** 2013-05
- **CT.gov Last Update:** 2013-06-19

## Brief Summary

This protocol defines the requirements to demonstrate that the PRO instruments which were designed as paper-based are equivalent to the nSpire Health ePRO (electronic patient reported outcome), following the ISPOR's ePRO Good Research Practices Task Force recommendations. All validation studies of the questionnaires were conducted using the original paper versions.

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 75 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Give their signed written informed consent to participate
* Current symptoms COPD, as diagnosed by a physician
* Age 40 - 75 years
* Able to read and understand English

Exclusion Criteria:

• Unwilling to complete the 3 electronic PRO questionnaires or participate in an interview during completion of questionnaires
```

## Primary Outcomes

- **Demonstrate that the following PRO instruments which were designed as paper-based are equivalent to the nSpire Health ePRO (electronic patient reported outcome)** _(time frame: 60 minutes)_ — The primary measures to demonstrate equivalency of electronic to paper PRO instruments are Usability and Cognitive Debriefing.

Usability data is gathered using systematic observation under controlled conditions to determine how well the device may be used by subjects.

Qualitative, Content Analysis of Cognitive Debriefing Data The cognitive debriefing data will be content analyzed for subject understanding of the instructions on the device used to deliver the PRO instrument.

## Recent Field Changes (last 30 days)

- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01875302.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01875302*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*